$255.00
Retatrutide enhances glucagon production, leading to the breakdown of stored fats and glycogen, thereby increasing basal metabolism for more consistent fat loss. Its actions on GLP-1 and GIP receptors promote delayed gastric emptying and appetite control, offering a comprehensive approach to obesity research distinct from older GLP-1 agonists. Further research is needed.
It is a GGG tri-agonist that targets GLP-1 and GIP receptors, akin to standard GLP-1 agonists, but also uniquely activates the glucagon receptor. This extra receptor interaction enhances glucagon production, leading to the breakdown of stored fats and glycogen, thereby increasing basal metabolism for more consistent fat loss. Its actions on GLP-1 and GIP receptors promote delayed gastric emptying and appetite control, offering a comprehensive approach to obesity research distinct from older GLP-1 agonists.
Research Use Only. Not For Human or Veterinary Use.
Veteran Peptides and its founders, employees, and affiliates (collectively referred to as “Veteran Peptides”) provide this website and its contents for informational and educational purposes only. The compounds offered by Veteran Peptides are intended for research purposes only and are not for human or veterinary use, unless explicitly declared.
By purchasing or using these compounds, you acknowledge and agree that Veteran Peptides shall not be held liable for any direct, indirect, incidental, consequential, or punitive damages arising from the use of, or reliance on, the information or products provided. You accept full responsibility for your use of these compounds and agree to comply with all applicable laws and regulations governing their handling and use.
By proceeding with this purchase, you affirm that you understand this disclaimer and that you are responsible for your own research and experimentation.
